×
Omnicell Long Term Debt 2010-2025 | OMCL
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Omnicell long term debt from 2010 to 2025. Long term debt can be defined as the sum of all long term debt fields.
View More
Omnicell Long Term Debt 2010-2025 | OMCL
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Omnicell long term debt from 2010 to 2025. Long term debt can be defined as the sum of all long term debt fields.
Related Stocks
Company Name
Market
Cap
Veeva Systems (VEEV)
$45.2B
Doximity (DOCS)
$11.6B
Hims & Hers Health (HIMS)
$11.2B
Tempus AI (TEM)
$10.5B
IRhythm Technologies (IRTC)
$4.3B
Inspire Medical Systems (INSP)
$3.8B
Hinge Health (HNGE)
$3.6B
Privia Health (PRVA)
$2.5B
Enovis (ENOV)
$1.8B
Schrodinger (SDGR)
$1.6B
Phreesia (PHR)
$1.5B
10x Genomics (TXG)
$1.5B
Clover Health Investments (CLOV)
$1.5B
Azenta (AZTA)
$1.5B
Evolent Health (EVH)
$1.3B
Claritev (CTEV)
$733M
Fulgent Genetics (FLGT)
$552M
Veradigm (MDRX)
$531M
Standard BioTools (LAB)
$475M
Butterfly Network (BFLY)
$457M
Talkspace (TALK)
$422M
TruBridge (TBRG)
$328M
Outset Medical (OM)
$312M
Nyxoah SA (NYXH)
$282M
Health Catalyst (HCAT)
$261M
SOPHiA GENETICS SA (SOPH)
$250M
CapsoVision (CV)
$218M
Zepp Health (ZEPP)
$206M
KORU Medical Systems (KRMD)
$152M
American Well (AMWL)
$126M